• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童感染 SARS-CoV-2 及其对疫苗接种的影响。

SARS-CoV-2 infection in children and implications for vaccination.

机构信息

School of Medicine, Deakin University, Geelong, VIC, Australia.

Department of Medicine, Alfred Health, Melbourne, VIC, Australia.

出版信息

Pediatr Res. 2023 Apr;93(5):1177-1187. doi: 10.1038/s41390-022-02254-x. Epub 2022 Aug 15.

DOI:10.1038/s41390-022-02254-x
PMID:35970935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9376896/
Abstract

The COVID-19 pandemic caused by novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for more than 500 million cases worldwide as of April 2022. Initial estimates in 2020 found that children were less likely to become infected with SARS-CoV-2 and more likely to be asymptomatic or display mild COVID-19 symptoms. Our early understanding of COVID-19 transmission and disease in children led to a range of public health measures including school closures that have indirectly impacted child health and wellbeing. The emergence of variants of concern (particularly Delta and Omicron) has raised new issues about transmissibility in children, as preliminary data suggest that children may be at increased risk of infection, especially if unvaccinated. Global national prevalence data show that SARS-CoV-2 infection in children and adolescents is rising due to COVID-19 vaccination among adults and increased circulation of Delta and Omicron variants. To mitigate this, childhood immunisation programmes are being implemented globally to prevent direct and indirect consequences of COVID-19 including severe complications (e.g., MIS-C), debilitating long-COVID symptoms, and the indirect impacts of prolonged community and school closures on childhood education, social and behavioural development and mental health. This review explores the current state of knowledge on COVID-19 in children including COVID-19 vaccination strategies. IMPACT: Provides an up-to-date account of SARS-CoV-2 infections in children. Discusses the direct and indirect effects of COVID-19 in children. Provides the latest information on the current state of global COVID-19 vaccination in children.

摘要

截至 2022 年 4 月,由新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)引起的 COVID-19 大流行在全球范围内已导致超过 5 亿例病例。2020 年的初步估计发现,儿童感染 SARS-CoV-2 的可能性较小,更有可能无症状或出现轻度 COVID-19 症状。我们对儿童 COVID-19 传播和疾病的早期认识导致了一系列公共卫生措施的实施,包括学校关闭,这间接影响了儿童的健康和幸福感。关注的变异体(特别是 Delta 和 Omicron)的出现引发了关于儿童传播性的新问题,因为初步数据表明儿童感染的风险可能增加,特别是如果未接种疫苗的话。全球国家流行数据显示,由于成年人接种 COVID-19 疫苗以及 Delta 和 Omicron 变异体的传播增加,儿童和青少年的 SARS-CoV-2 感染率正在上升。为了减轻这种情况,全球正在实施儿童免疫计划,以预防 COVID-19 包括严重并发症(例如,MIS-C)、长期 COVID 症状和长期社区和学校关闭对儿童教育、社会和行为发展以及心理健康的间接影响。这篇综述探讨了 COVID-19 在儿童中的现状,包括 COVID-19 疫苗接种策略。影响:提供了 SARS-CoV-2 感染儿童的最新信息。讨论了 COVID-19 在儿童中的直接和间接影响。提供了全球儿童 COVID-19 疫苗接种现状的最新信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fa/9376896/94680161d334/41390_2022_2254_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fa/9376896/1c7667fe7e6a/41390_2022_2254_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fa/9376896/94680161d334/41390_2022_2254_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fa/9376896/1c7667fe7e6a/41390_2022_2254_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fa/9376896/94680161d334/41390_2022_2254_Fig2_HTML.jpg

相似文献

1
SARS-CoV-2 infection in children and implications for vaccination.儿童感染 SARS-CoV-2 及其对疫苗接种的影响。
Pediatr Res. 2023 Apr;93(5):1177-1187. doi: 10.1038/s41390-022-02254-x. Epub 2022 Aug 15.
2
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
3
COVID-19 in Children: Where do we Stand?儿童 COVID-19:我们处于什么位置?
Arch Med Res. 2022 Jan;53(1):1-8. doi: 10.1016/j.arcmed.2021.07.002. Epub 2021 Jul 6.
4
A systematic review of current status and challenges of vaccinating children against SARS-CoV-2.儿童接种 SARS-CoV-2 疫苗的现状与挑战的系统综述。
J Infect Public Health. 2022 Nov;15(11):1212-1224. doi: 10.1016/j.jiph.2022.10.006. Epub 2022 Oct 13.
5
Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study.了解严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)德尔塔和奥密克戎变异株在澳大利亚学校和儿童保育场所的传播情况及疫苗影响:一项基于人群的研究
Lancet Reg Health West Pac. 2023 Jun;35:100736. doi: 10.1016/j.lanwpc.2023.100736. Epub 2023 Mar 22.
6
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.SARS-CoV-2 变体和疫苗接种率在 Delta 变体出现期间面临的全球大流行:一项旨在寻找疫苗犹豫原因的全国性调查。
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
7
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
8
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.儿童感染前奥密克戎变异株后对关注的 SARS-CoV-2 变异株的抗体反应:一项观察性队列研究。
EBioMedicine. 2022 Sep;83:104230. doi: 10.1016/j.ebiom.2022.104230. Epub 2022 Aug 18.
9
Routine SARS-CoV-2 vaccination for all children.常规接种 SARS-CoV-2 疫苗。
Immunol Rev. 2022 Aug;309(1):90-96. doi: 10.1111/imr.13108. Epub 2022 Jul 7.
10
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.

引用本文的文献

1
Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study.两剂科兴疫苗接种方案(巴西Immunita-002)后儿童和青少年对奥密克戎亚型BA.1和BA.5的中和抗体反应:一项为期12个月的纵向研究
Front Immunol. 2025 Jul 15;16:1589733. doi: 10.3389/fimmu.2025.1589733. eCollection 2025.
2
SARS-CoV-2 seroprevalence among learners in grades 1-7, their parents and teachers in KwaZulu-Natal, South Africa: a cross-sectional study.南非夸祖鲁-纳塔尔省1至7年级学生及其家长和教师中SARS-CoV-2血清流行率:一项横断面研究。
Front Public Health. 2025 May 2;13:1548945. doi: 10.3389/fpubh.2025.1548945. eCollection 2025.
3

本文引用的文献

1
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.DNA SARS-CoV-2 疫苗(ZyCoV-D)的有效性、安全性和免疫原性:在印度进行的 3 期、随机、双盲、安慰剂对照研究的中期疗效结果。
Lancet. 2022 Apr 2;399(10332):1313-1321. doi: 10.1016/S0140-6736(22)00151-9.
2
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.0-4 岁确诊感染 COVID-19 的婴幼儿住院情况-COVID-NET,14 个州,2020 年 3 月-2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429-436. doi: 10.15585/mmwr.mm7111e2.
3
The COVID-19 pandemic in children and young people during 2022-24: what new did we learn?
2022年至2024年期间儿童和青少年中的新冠疫情:我们有哪些新认识?
J Glob Health. 2025 Apr 2;15:01002. doi: 10.7189/jogh.15.01002.
4
Exploring long-term psychological effects of bronchiolitis and influenza in school-aged children.探索细支气管炎和流感对学龄儿童的长期心理影响。
Front Pediatr. 2025 Mar 10;13:1536571. doi: 10.3389/fped.2025.1536571. eCollection 2025.
5
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.一项针对3至17岁儿童的鼻内SARS-CoV-2疫苗dNS1-RBD的随机I期试验。
NPJ Vaccines. 2025 Mar 17;10(1):50. doi: 10.1038/s41541-025-01096-y.
6
Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?欧洲和南非感染艾滋病毒的儿童及青少年感染新冠病毒的风险更高且感染新冠病毒后病情更严重吗?
Epidemiol Infect. 2025 Feb 21;153:e44. doi: 10.1017/S0950268825000135.
7
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis.解读疫苗接种情况:通过系统评价和荟萃分析探讨沙特阿拉伯父母让孩子接种新冠疫苗的意愿。
PLoS One. 2025 Jan 27;20(1):e0317983. doi: 10.1371/journal.pone.0317983. eCollection 2025.
8
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies.DNA 和 RNA 结核病疫苗:人体和动物研究的范围综述。
Front Immunol. 2024 Oct 3;15:1457327. doi: 10.3389/fimmu.2024.1457327. eCollection 2024.
9
Mpox in sports: A comprehensive framework for anticipatory planning and risk mitigation in football based on lessons from COVID-19.体育领域的猴痘:基于新冠疫情经验教训的足球前瞻性规划与风险缓解综合框架
Biol Sport. 2024 Oct;41(4):317-335. doi: 10.5114/biolsport.2024.144014. Epub 2024 Oct 10.
10
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection.SARS-CoV-2奥密克戎感染后接种疫苗和未接种疫苗儿童的体液免疫和细胞免疫反应。
Clin Transl Immunology. 2024 Oct 3;13(10):e70008. doi: 10.1002/cti2.70008. eCollection 2024.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
辉瑞-生物科技 BNT162b2 mRNA 疫苗预防非免疫功能低下 5-17 岁儿童和青少年与 COVID-19 相关的急诊和紧急护理就诊及住院的有效性 - VISION 网络,10 个州,2021 年 4 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 4;71(9):352-358. doi: 10.15585/mmwr.mm7109e3.
4
Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.南非首次出现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变异株疫情期间因新冠病毒病住院的儿童:一项多中心观察性研究
Lancet Child Adolesc Health. 2022 May;6(5):294-302. doi: 10.1016/S2352-4642(22)00027-X. Epub 2022 Feb 18.
5
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.2021 年 11 月 3 日至 12 月 19 日,美国 5-11 岁儿童的 COVID-19 疫苗安全性。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1755-1760. doi: 10.15585/mmwr.mm705152a1.
6
Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.法国青少年 COVID-19 疫苗接种状况与儿童多系统炎症综合征的关系。
JAMA. 2022 Jan 18;327(3):281-283. doi: 10.1001/jama.2021.23262.
7
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.自然免疫对SARS-CoV-2贝塔变异株再感染的效力
N Engl J Med. 2021 Dec 30;385(27):2585-2586. doi: 10.1056/NEJMc2110300. Epub 2021 Dec 15.
8
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.儿童与SARS-CoV-2相关的多系统炎症综合征最新情况
Pediatr Infect Dis J. 2022 Jan 1;41(1):e6-e9. doi: 10.1097/INF.0000000000003393.
9
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
10
Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021.2020 年 8 月至 2021 年 8 月期间,0-17 岁儿童和青少年的 COVID-19 病例、急诊就诊和住院趋势-美国。
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254. doi: 10.15585/mmwr.mm7036e1.